UNH Research Note — Better Headlines, Unresolved Costs
UnitedHealth’s better quarter did not settle the medical-cost debate as the shares reversed sharply despite broader health-care leadership.
UNH
UNH Deep Coverage Review — Analysis as of July 27, 2026
UnitedHealth’s valuation and dividend support the franchise, but medical-cost uncertainty and a failed breakout leave stabilization unconfirmed.